At any one time in this country 50 to 100,000 people are suffering from heart failure, but only about 2,000 people a year receive heart transplants. For some people, an LVAD device can help patients ...

MedStar Washington Hospital Center has reached a major milestone in cardiac care by completing more than 500 HeartMate 3 Left ...

Let's say you're one of the nearly 7 million Americans with heart failure. Your heart’s ability to pump blood is impaired. Despite being on all the right medicines, at doses as high as you can ...

Medtronic announced it has received a breakthrough device designation from the FDA for its fully implantable left ventricular assist device for patients with advanced HF. Perspective from Frank Smart, ...

LVADs have been life-savers for decades and, for a number of years, hospitals had a choice of two devices - the HeartWare ...

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/rglp75/global_left) has announced the addition of the "Global Left ...

Las Vegas, NV - The preliminary results from a large prospective study of cardiac function during left ventricular assist device (LVAD) support have found that left ventricular ejection fraction (LVEF ...

Medicare beneficiaries with heart failure who are Black or female were less likely to receive a left ventricular assist device (LVAD) implantation compared with White and male beneficiaries. Between ...

VenstraMedical announced that it secured an investment to accelerate the development of its percutaneous ventricular assist ...

Heart failure is one of the most pressing health challenges of our time, affecting over 64 million people worldwide and driving significant mortality, morbidity, and healthcare costs. As donor heart ...

TikToker Sofia Hart documents life with an LVAD — a device that keeps her heart pumping — while she awaits a heart transplant When Sofia Hart wakes up in the morning, she brushes her teeth and makes ...

The NyokAssist device, from China, had few adverse outcomes by 30 days. More devices—and more trials—are on the way.